Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Jill Roberts
Another way to know what’s too old to eat
Patricia Santos-Serrao
Four pharma quality trends
Del Williams
Preventing damage caused by large, suspended particles
Kari Miller
An effective strategy requires recruiting qualified personnel familiar with the process and technology

More Features

FDA Compliance News
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community
Good quality is adding an average of 11 percent to organizations’ revenue growth
Further enhances change management capabilities
Creates adaptive system for managing product development and post-market quality for devices with software elements
VQIP allows for expedited review and importation for approved applicants that demonstrate safe supply chains

More News


FDA Compliance

FDA in China

Published: Tuesday, March 25, 2008 - 22:00

(FDA: Rockville, Maryland) -- In an effort to facilitate stronger cooperative relationships with its counterpart agencies around the world, the United States Food and Drug Administration (FDA) plans to establish eight full-time, permanent positions at U.S. diplomatic posts in the People’s Republic of China, pending authorization from the Chinese government.

The move is expected to enhance technical cooperation with foreign regulators and allow greater access for inspections and interactions with manufacturers. By placing FDA personnel in the country, it’s hoped that future products that are shipped to the United States will meet U.S. standards for safety and manufacturing quality.

"In an age when a border is not a barrier, the globalized economy demands nothing less than heightened regulatory interoperability, information exchange, and cooperation, especially on product quality and enforcement matters," says Murray M. Lumpkin, M.D., deputy commissioner for International and Special Programs at the FDA. "Along with the important memoranda of agreement signed with two FDA counterpart Chinese agencies, our efforts to fill permanent FDA positions in China are a significant step toward ensuring access to safe food, drugs, and medical devices in the global market."

This is also an important step forward in the FDA’s plans to hire and place FDA staff in China over the next 18 months. In addition, the FDA will be hiring a total of five local Chinese nationals to work with the new FDA staff at the U.S. Embassy in Beijing and the U.S. Consulates General in Shanghai and Guangzhou.

For further information, visit www.fda.gov/bbs/topics/NEWS/2008/NEW01806.html


About The Author

FDA’s picture


The U.S. Food and Drug Administration (FDA) is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable, and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.